← Leaderboards
Nebojsa Duric
Delphinus Medical Technologies, Inc.
$4,864,672
Attributed
$5,954,382
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $984.7K · FY2012–22$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,954,382 · 2
By mechanism
R44$3,774,962 · 1
R01$2,179,420 · 1
Top collaborators
- Mark A Anastasio4 shared
Most similar at Delphinus Medical Technologies, Inc.
Same institution · by research overlap
- Cuiping Li$633,232
- Olivier Roy$679,920
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingMalignant Breast NeoplasmDiagnosticTissuesBreastImageMammographyDetectionUltrasonographyTomographyMorphologic ArtifactsBaseImaging ModalitySoundModalityX-Ray Computed TomographyAttenuationRadiationAdoptionSpecificityReaderBreast ImagingPublic Health RelevanceRadiologist
Grant awards (10)
Advanced image reconstruction for accurate and high-resolution breast ultrasound tomography$574,942
R01 · FY2022 · EB
Advanced image reconstruction for accurate and high-resolution breast ultrasound tomography$556,906
R01 · FY2021 · EB
Advanced image reconstruction for accurate and high-resolution breast ultrasound tomography$516,538
R01 · FY2020 · EB
Advanced image reconstruction for accurate and high-resolution breast ultrasound tomography$531,034
R01 · FY2019 · EB
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$857,782
R44 · FY2018 · CA · contact PI
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$962,653
R44 · FY2017 · CA · contact PI
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.$984,706
R44 · FY2016 · CA · contact PI
Transitioning the SoftVue Breast Scanner to the clinical marketplace$431,147
R44 · FY2014 · CA · contact PI
Transitioning the SoftVue Breast Scanner to the clinical marketplace$429,516
R44 · FY2013 · CA · contact PI
Transitioning the SoftVue Breast Scanner to the clinical marketplace$109,158
R44 · FY2012 · CA · contact PI